Skip to main content

Advertisement

SpringerLink
Log in

Pediatrics

Neuroprotective effects of erythropoietin in preterm infants

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

The dramatic increase in survival of extremely premature infants has been associated with a growing population of individuals with neurodevelopmental disabilities. To date, clinical trials of neuroprotective agents in preterm infants have been limited, but new data suggest that erythropoietin might have important neuroprotective effects in these vulnerable infants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mikkola, K. et al. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996–1997. Pediatrics 116, 1391–1400 (2005).

    Article  Google Scholar 

  2. Gonzalez, F. F. et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev. Neurosci. 29, 321–330 (2007).

    Article  CAS  Google Scholar 

  3. Juul, S. E. et al. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev. Neurosci. 30, 231–242 (2008).

    Article  CAS  Google Scholar 

  4. Siren, A. L., Fasshauer, T., Bartels, C. & Ehrenreich, H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6, 108–127 (2009).

    Article  CAS  Google Scholar 

  5. Neubauer, A. P., Voss, W., Wachtendorf, M. & Jungmann, T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann. Neurol. doi: 10.1002/ana.21977.

  6. Sola, A., Wen, T. C., Hamrick, S. E. & Ferriero, D. M. Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr. Res. 57, R110–R117 (2005).

    Article  Google Scholar 

  7. Bierer, R., Peceny, M. C., Hartenberger, C. H. & Ohls, R. K. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118, e635–e640 (2006).

    Article  Google Scholar 

  8. Brown, M. S., Eichorst, D., Lala-Black, B. & Gonzalez, R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 124, e681–e687 (2009).

    Article  Google Scholar 

  9. Newton, N. R., Leonard, C. H., Piecuch, R. E. & Phibbs, R. H. Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy. J. Perinatol. 19, 403–406 (1999).

    Article  CAS  Google Scholar 

  10. Ohls, R. K. et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114, 1287–1291 (2004).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Montreal Children's Hospital, Pediatric Neurology, 2300 Tupper Street A-334, Montreal, H3H 1P3, QC, Canada

    Catherine Limperopoulos

Authors
  1. Catherine Limperopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Limperopoulos, C. Neuroprotective effects of erythropoietin in preterm infants. Nat Rev Neurol 6, 301–302 (2010). https://doi.org/10.1038/nrneurol.2010.66

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2010.66

  • Springer Nature Limited

Search

Navigation